The market for hereditary testing is predicted to expand significantly in the next years due to the rise in cancer and genetic illnesses, as well as increased knowledge and acceptance of personalized therapy. Pharmacogenomics, often known as drug-gene testing, has frequently used hereditary testing. Improvements in genetic testing methods are anticipated to accelerate market expansion.
